Navigation Links
Ribonuclease in Biological Technology

Alfacell Provides ONCONASE(R) NDA Submission Update

... as of January 1, 2009. About ONCONASE (R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells

... in this disease. About ONCONASE (R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results

... clinical development program." About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Paper in Cell Cycle Reports Alfacell's ONCONASE(R) Targets siRNA

... that failed prior chemotherapy." About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Hires Advisors to Advance Strategic Alternatives

... has approved a specific transaction. About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Reports Financial Results for Third Quarter of Fiscal 2008

... site at http://www.alfacell.com . About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Announces Retirement of Chief Executive Officer

... foundation she has built for us." About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Reports Financial Results for Second Quarter of Fiscal 2008

... site at http://www.alfacell.com . About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories

... and straight through to commercial launch. About ONCONASE(R) ONCONASE is a first-in-class product candidate from Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29

... will Include World-Renowned RNase and RNA Researchers SOMERSET, N.J., Oct. 25 /PRNewswire-FirstCall/ -- The RNA interference- like mechanics of ribonuclease (RNase) therapeutics will be the focus of scientific presentations in a Nov. 29 Webinar hosted by Alfacell Corporation (Nasdaq: ACEL ). Moderated ...

Nuclease Protection Assays: The Basics

... Nuclease protection assays (NPAs), including both ribonuclease protection assays (RPAs) and S1 ... flexibility. The most common type of NPA, the ribonuclease protection assay, requires ... Inhibition of ribonuclease activity ...

Combat RNase Contamination in the Lab

... Trace amounts of ribonuclease (RNase) contamination can ... Figure 1. SUPERaseIn vs. Placental ribonuclease Inhibitor (RI). A 32 P-labeled RNA probe was ... RNase inhibitor is placental ribonuclease inhibitor (RI), sold ...

Detecting miRNA & siRNA

... RNA probe were removed by a brief ribonuclease digestion. Protected target RNA fragments were ... a reagent that simultaneously inactivates the ribonuclease and precipitates the nucleic acid. The ... hybridization assay based on ribonuclease protection can sensitively and ...

Northern Analysis: The Basics

... disruption Inhibition of ribonuclease activity Deproteinization ... Zap , a nontoxic ribonuclease decontamination solution for equipment and work ...

Measuring RNase Activity A Real-time Kinetic Analysis

... the removal of contaminating RNA from DNA preparations and ribonuclease protection assays (RPA). Ambion sells an RPA grade RNase A ... B (1960) Spectrophotometric assay of bovine pancreatic ribonuclease by the use of cytidine 2',3'-phosphate. Biochem. J. 74 ...

Detecting Attomole Amounts of Small RNA

... and excess RNA probe is then removed by a rapid ribonuclease digestion step. The hybridized, protected RNA ... patented single step technology for simultaneous ribonuclease inactivation and nucleic acid precipitation. RNA ...

Americas Third Coast nurtures biotechnology

... RNA is essential for life, ribonucleases can be toxic to cells, especially rapidly proliferating cancer cells. However, cells also contain natural ribonuclease inhibitors (RI), which bind ribonucleases to prevent cell destruction. The Evade technology genetically modifies selected ribonucleases to prevent ...

Quintessence Biosciences forms cancer therapeutic advisory board

... T. Raines, Ph.D., professor of biochemistry and chemistry at UW-Madison, co-founder of Quintessence Biosciences, Inc. and inventor of the EVade ribonuclease technology Paul M. Sondel, M.D., Ph.D., professor in the departments of pediatrics, human oncology and genetics at the University of Wisconsin ...

Quintessence cancer treatment chosen for clinical studies

... drug application in late 2007, with human clinical trials expected to begin in early 2008. The company is developing new drugs based on its EVade ribonuclease technologies. In pre-clinical disease models, the QB139 compound demonstrated safe tumor-growth inhibition in vivo (inside the body) against ...

Quintessence Biosciences advances cancer drug

... cancer. As the company's lead cancer drug, QBI-139 represents the first in a series of oncology products advancing from the company's EVade ribonuclease development program. The AACR meeting provides Quintessence with an opportunity to report information on its emerging drug candidates, and perhaps ...

RNA Interference and Gene Silencing: History and Overview

... & Development 12 :225-232. Bernstein E, Caudy AA, Hammond SA, and Hannon GJ. (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409 :363-366. Nykanen A, Haley B, and Zamore PD. (2001) ATP ...

Recombinant HIV Reverse Transcriptase

... times. Reactions were performed using the manufacturer-supplied reaction buffer in the presence of * 32 -P dUTP and 0.5 U/l ribonuclease inhibitor. The percentage cDNA conversion was determined by measuring the amount of cDNA made via scintillation counting. ...

Getting Started with MicroRNA Research

... structure that likely forms around the miRNA sequence of the pri-miRNA acts as a signal for digestion by a double-stranded (ds) ribonuclease (Drosha) to produce the precursor miRNA (Pre-miRNA). (3) Exportin-5 mediates nuclear export of pre-miRNAs. (4) A ...

MicroRNA Profiling by Array Analysis Reveals Critical BioMarkers

... as parts of longer RNA molecules [7] that are processed in the nucleus into hairpin RNAs of 70-100 nucleotides by the dsRNA-specific ribonuclease Drosha [8] (Figure 1). The hairpin RNAs are transported to the cytoplasm and digested by a second, double-strand specific ...

Designing Controls for siRNA Experiments

... synthetase catalyzes the synthesis of 2'-5' polyadenylic acid, which activates the nonspecific ribonuclease RNase L. Another way is to monitor activation of the dsRNA-dependent protein kinase, PKR, which is involved in ...

Improve RNA Isolation for Array Analysis and More

... are difficult to disrupt (e.g. muscle, fibrous plant tissue, yeast, bacteria), or samples that are high in ribonuclease or other contaminants (e.g. spleen, pancreas, plant and neural tissues). RiboPure is the method of choice ...

RNase Protection Assay (RPA) Using DIG-Labeled RNA Probes

... The ribonuclease protection assay (RPA) is a highly sensitive and specific method for the detection and quantitation of mRNA species. The assay was made ...

Reliable Assessment of Micronuclei for Genotoxicity Testing in Mice or Rats

... against these surface markers can differentially label immature erythrocytes. 9,10 When fixed blood cells are treated with ribonuclease and antitransferrin receptor antibody (FITC-conjugate), and then stained with propidium iodide, normochromatic erythrocytes (NCEs) ...
Other Contents
(Date:8/22/2014)... Stanford, CAEveryone,s heard of the birds and the ... flowers that are being fertilized. The fertilization process ... extensive communication between the male and female reproductive ... Stanford, Regensburg, Heidelberg, and Munich, and including Carnegie,s ... discoveries in the chemical signaling process that guides ...
(Date:8/21/2014)... study of American singles found that during sex ... orgasm rates. On average, men experience orgasm 85.1 ... making little difference. For women, however, orgasm occurrence ... 62.9 percent of the time during sex with ... with women,s sexual orientation, with lesbian women experiencing ...
(Date:8/21/2014)... Algae might seem easy to ignore, but they are ... animals depend upon. Humans are increasingly dependent on algae, ... atmosphere and sink it to the bottom of the ... and laboratory experiments, researchers have evidence showing that viruses ... the algae,s blooms, even when all else stays essentially ...
Breaking Biology News(10 mins):Calcium and reproduction go together 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 3Orgasm rates for single women less predictable than men's, vary by sexual orientation 4Viruses take down massive algal blooms, with big implications for climate 2
(Date:8/23/2014)... 23, 2014 "I have heard female ... a urine sample," said an inventor from Lake Stevens, ... and mess-free, I came up with this urine-collection aid." ... samples to be collected from women more easily. The ... to patients and staff. The invention improves sanitation and ...
(Date:8/23/2014)... Peripheral intervention surgeries are part of ... thereby addressing the root cause of peripheral artery disease. ... the other part of the arteries where the blood ... require the use of a catheter, (which is a ... catheters are inserted through a thin cut in an ...
(Date:8/23/2014)... A team of New York researchers say ... preceded by surgery and delivered by an experienced team. Surviving ... Click here to read it now . , ... of mesothelioma patients who underwent hemithoracic (one side of ... the shape of a tumor. Patients who had surgery ...
(Date:8/23/2014)... GBI Research, the leading business intelligence provider, has ... Developed Markets to 2020 - New and Late-Stage Four-Factor ... in-depth analysis of the critical care market in the ... The report provides an estimation of market size for ... critical care indications that are being treated using the ...
(Date:8/23/2014)... Young adults in Athens, GA who find that they have a ... and call the new helpline which can offer support and guidance ... Teen Athens is a wonderful resource for an adolescent drug or ... to end substance abuse once and for all. When a young ... peers when really they should put their faith in a youth ...
Breaking Medicine News(10 mins):Health News:Global Peripheral Intervention Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Health News:Global Peripheral Intervention Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Health News:Global Peripheral Intervention Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Health News:New Study Links Hospital Experience and Prior Surgery with Mesothelioma Radiation Success, According to Surviving Mesothelioma 2Health News:Critical Care Therapeutics in Major Developed Markets to 2020 | Researchmoz 2Health News:Critical Care Therapeutics in Major Developed Markets to 2020 | Researchmoz 3Health News:Teenagers in Athens, GA are Locating Addiction Recovery Thanks to New Helpline 2
Other TagsOther Tags